Skip to main content
Livermore
Livermore
ZHEN

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

DMAC holding history

DiaMedica Therapeutics Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DMAC overviewAll 13F holders of DMACFull Q2 2026 holdings

Shares (Q2 2026)
145,870
Value
$1.03M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of DMAC by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026145,870$1.03M<0.1%+146+0.1%AddedHolders
Q1 2026145,724$986.6K<0.1%+34,987+31.6%AddedHolders
Q4 2025110,737$881.5K<0.1%+41,385+59.7%AddedHolders
Q3 202569,352$476.4K<0.1%+69,352NewHolders
Q2 20250$00.0%−53,700−100.0%Sold outHolders
Q1 202553,700$203.5K<0.1%+37,587+233.3%AddedHolders
Q4 202416,113$87.5K<0.1%+4,282+36.2%AddedHolders
Q3 202411,831$49.6K<0.1%+3,418+40.6%AddedHolders
Q2 20248,413$24.8K<0.1%−15,607−65.0%ReducedHolders
Q1 202424,020$66.5K<0.1%+1,305+5.7%AddedHolders
Q4 202322,715$64.5K<0.1%+6,847+43.1%AddedHolders
Q3 202315,868$40.9K<0.1%+7,956+100.6%AddedHolders
Q2 20237,912$34.2K<0.1%−34,322−81.3%ReducedHolders
Q1 202342,234$64.6K<0.1%+3,018+7.7%AddedHolders
Q4 202239,216$62.0K<0.1%+4,304+12.3%AddedHolders
Q3 202234,912$43.0K<0.1%+16,900+93.8%AddedHolders
Q2 202218,012$36.0K<0.1%−20,220−52.9%ReducedHolders
Q1 202238,232$96.0K<0.1%−27,368−41.7%ReducedHolders
Q4 202165,600$245.0K<0.1%+29,746+83.0%AddedHolders
Q3 202135,854$144.0K<0.1%+10,456+41.2%AddedHolders
Q2 202125,398$113.0K<0.1%+4,797+23.3%AddedHolders
Q1 202120,601$189.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.